News
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 January 2026
Dexa Group’s Consistent Reputation Management Wins the 8th Indonesia Public Relations Awards
Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…
5 January 2026
Understanding the “K” Symbol on Medicine Packaging
Amid ongoing public discussions regarding the use of prescription medicines, it is important for the public to understand the meaning of the symbol displayed on medicine packaging. The red circle symbol with the letter “K” does not indicate that the medicine is dangerous; rather, it signifies that the product is…
30 December 2025
Right to Win Through Visionary Leadership: Dexa Group Wins the Indonesia CEO Excellence Award 2025
Dexa Group has once again achieved a strategic milestone by receiving the Indonesia CEO Excellence Award 2025, organized by WartaEkonomi.co.id Research and Consulting. This award recognizes visionary leadership that consistently drives business sustainability while strengthening the pharmaceutical sector’s contribution to national health resilience. The award was presented by Muhamad Ihsan,…
10 December 2025
Karya Anak Bangsa 2025 Award Presented to Dexa Medica for Strategic Contribution to Advancing Indonesia’s Health Innovation
JAKARTA – On the occasion of the 61st National Health Day (HKN), Dexa Medica achieved a significant milestone by receiving the Karya Anak Bangsa Award from the Ministry of Health of the Republic of Indonesia, recognizing it as the pharmaceutical industry with the highest number of clinical trials for natural-based…
25 November 2025
DLBS Brings Indonesia’s Biodiversity to the Global Pharmaceutical Stage at CPHI Frankfurt 2025
As global interest in herbal medicines continues to grow, only a limited number of products are developed with rigorous scientific methods and supported by strong clinical evidence. DLBS addresses this gap through the development of Integrative Modern Natural Medicines—therapeutics based on defined bioactive fractions with clear mechanisms of action and…